UPDATE 1-Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

NEW YORK, Jan 30 (Reuters) - Three of the biggest makers of

diabetes treatments, Sanofi SA, Novo Nordisk

and Eli Lilly & Co, were named in a class

action lawsuit about price fixing filed by a group of patients.

Read more